Transfusion and Apheresis Science
Volume 42, Issue 3 , Pages 277-281 , June 2010

Cord blood transplantation in patients with hemoglobinopathies

  • Agata Boncimino
    • ,
  • Alice Bertaina
    • ,
  • Franco Locatelli

      Affiliations

    • Corresponding Author InformationCorrespondence to: Franco Locatelli, Oncoematologia Pediatrica, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, P.le Golgi, 2, I-27100 Pavia, Italy. Tel.: +39 0382 502912; fax: +39 0382 501251.

References 

  1. Olivieri NF. The β-thalassemia. New Engl J Med. 1999;34:99–109
  2. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. New Engl J Med. 1994;330:1639–1644
  3. Walters MC, Nienhuis AW, Vichinsky E. Novel therapeutic approaches in sickle cell disease. Hematology (Am Soc Hematol Educ Program). 2002;319–338
  4. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, et al. Survival and causes of death in thalassemia major. Lancet. 1989;2:27–30
  5. Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, Gamberoni MR, et al. Survival and disease complications in thalassemia major. Ann NY Acad Sci. 1998;850:227–231
  6. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89:739–761
  7. Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia register. Lancet. 2000;355:2051–2052
  8. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89:1187–1193
  9. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006;107:3455–3462
  10. Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood. 2006;107:3733–3737
  11. Piga A, Longo F, Consolati A. Mortality and morbidity in thalassaemia with conventional treatment. Bone Marrow Transplant. 1997;19:11–13
  12. Locatelli F, De Stefano P. New insights into haematopoietic stem cell transplantation for patients with haemoglobinopathies. Br J Haematol. 2004;125:3–11
  13. Thomas ED, Buckner CD, Sanders JE, Papayannopoulou T, Borgna-Pignatti C, De Stefano P, et al. Marrow transplantation for thalassemia. Lancet. 1982;2:227–229
  14. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med. 1990;322:417–421
  15. Lucarelli G, Clift RA, Galimberti M, Polchi P, Angelucci E, Baronciani D, et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood. 1996;87:2082–2088
  16. Giardini C, Lucarelli G. Bone marrow transplantation for beta-thalassemia. Hematol Oncol Clin North Am. 1999;13:1059–1064
  17. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med. 1996;335:369–376
  18. Hoppe CC, Walters MC. Bone marrow transplantation in sickle cell anemia. Curr Opin Oncol. 2001;13:85–90
  19. Walters MC, Patience M, Leisenring W, Rogers ZR, Aquino VM, Buchanan GR, et al. Multicenter investigation of bone marrow transplantation for sickle cell disease. Stable mixed haematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 2001;7:665–673
  20. Storb RF, Lucarelli G, McSweeney PA, Childs RW. Hematopoietic cell transplantation for benign hematological disorders and solid tumors. Hematology (Am Soc Hematol Educ Program). 2003;372–397
  21. Locatelli F. Reduced-intensity regimens in allogeneic hematopoietic stem cell transplantation for hemoglobinopathies. Hematology (Am Soc Hematol Educ Program). 2006;398–401
  22. Lucarelli G, Clift RA, Galimberti M, Angelucci E, Giardini C, Baronciani D, et al. Bone marrow transplantation in adult thalassemic patients. Blood. 1999;93:1164–1167
  23. Bernaudin F, Socié G, Kuentz M, Chevret S, Duval M, Bertrand Y, et al. SFGM-TC. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood. 2007;110:2749–2756
  24. Gluckman E, Locatelli F. Umbilical cord blood transplants. Curr Opin Haematol. 2000;7:353–357
  25. Kurtzberg J. Update on umbilical cord blood transplantation. Curr Opin Pediatr. 2009;21:22–29
  26. Locatelli F. Improving cord blood transplantation in children. Br J Haematol. 2009;147:217–226
  27. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373:1550–1561
  28. Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and international bone marrow transplant registry working committee on alternative donor and stem cell sources. N Engl J Med. 2000;342:1846–1854
  29. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord transplant group and the European blood and marrow transplantation group. N Engl J Med. 1997;337:373–381
  30. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–1618
  31. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369:1947–1954
  32. Gluckman E. Cord blood transplantation. Biol Blood Marrow Transplant. 2006;12:808–812
  33. Issaragrisil S, Visuthisakchai S, Suvatte V, Tanphaichitr VS, Chandanayingyong D, Schreiner T, et al. Brief report: transplantation of cord-blood stem cells into a patient with severe thalassemia. N Engl J Med. 1995;332:367–369
  34. Lau YL, Ma ES, Ha SY, Chan GC, Chiu D, Tang M, et al. Sibling HLA-matched cord blood transplant for beta-thalassemia: report of two cases, expression of fetal hemoglobin and review of the literature. J Pediatr Hematol Oncol. 1998;20:477–481
  35. Brichard B, Vermylen C, Ninane J, Cornu G. Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. J Pediatr. 1996;128:241–243
  36. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S, et al. Eurocord transplant group. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003;101:2137–2143
  37. Gaziev D, Polchi P, Galimberti M, Angelucci E, Giardini C, Baronciani D, et al. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors. Transplantation. 1997;63:854–860
  38. Sullivan KM, Parkman R, Walters MC. Bone marrow transplantation for non-malignant disease. Hematology (Am Soc Hematol Educ Program). 2000;319–338
  39. Hall JG, Martin PL, Wood S, Kurtzberg J. Unrelated umbilical cord blood transplantation for an infant with beta-thalassemia major. J Pediatr Hematol Oncol. 2004;26:382–385
  40. Jaing TH, Hung IJ, Yang CP, Chen SH, Sun CF, Chow R. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major. Biol Blood Marrow Transplant. 2005;11:349–353
  41. Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J, et al. Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant. 2007;13:1073–1082
  42. Rocha V, Locatelli F. Searching for alternative donors of haematopoietic stem cell for paediatric patients. Bone Marrow Transplant. 2008;41:207–214
  43. Andreani M, Manna M, Lucarelli G, Tonucci P, Agostinelli F, Ripalti M, et al. Persistence of mixed chimerism in patients transplanted for treatment of thalassemia. Blood. 1996;87:3494–3499
  44. Andreani M, Nesci S, Lucarelli G, Tonucci P, Rapa S, Angelucci E, et al. Long term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone marrow transplantation. 2000;25:401–404
  45. Li CK, Chik KW, Tsang KS, Pong H, Shing MM, Yuen PM. Mixed chimerism after bone marrow transplantation for thalassemia major. Haematologica. 2002;87:781–782
  46. Lisini D, Zecca M, Giorgiani G, Montagna D, Cristantielli R, Labirio M, et al. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given allogeneic cord blood transplantation from an HLA-identical sibling. Haematologica. 2008;93:1859–1867
  47. Hill RS, Petersen FB, Storb R, Appelbaum FR, Doney K, Dahlberg S, et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood. 1986;67:811–816
  48. Locatelli F, Bruno B, Zecca M, Van-Lint MT, McCann S, Arcese W, et al. Cyclosporin A and short-term methotrexate versus cyclosporine A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood. 2000;96:1690–1697
  49. Reed W, Smith R, Dekovic F, Lee JY, Saba JD, Trachtenberg E, et al. Comprehensive banking of sibling donor cord blood for children with malignant and non-malignant disease. Blood. 2003;101:351–357
  50. Burgio GR, Gluckman E, Locatelli F. Ethical reappraisal of 15 years of cord blood transplantation. Lancet. 2003;361:250–252

PII: S1473-0502(10)00058-3

doi: 10.1016/j.transci.2010.03.006

Transfusion and Apheresis Science
Volume 42, Issue 3 , Pages 277-281 , June 2010

Article Tools

* Image Usage & Resolution